Abstract
Intravenous ribavirin was given to nine patients who had developed severe adenovirus-induced hemorrhagic cystitis (AD-HC) which was resistant to conventional therapy or where there was involvement of other organs after allogeneic BMT. Three patients recovered completely from AD-HC, two of whom had been resistant to vidarabine. All three had received sibling BMTs (2 HLA matched, 1 HLA mismatched). Five patients who received BMTs from related (2 HLA mismatched) or unrelated (1 HLA matched, 2 HLA mismatched) showed an improvement in symptoms but had recurrent AD-HC after discontinuation of ribavirin. Improvement in clinical symptoms and termination of virus excretion were well correlated. The last patient who received a mismatched unrelated BMT died during ribavirin therapy. Ribavirin was notably more effective among patients receiving BMTs from siblings in contrast to patients receiving BMTs from alternative donors (<0.05). One patient experienced severe pancytopenia during the second treatment with ribavirin after hc recurrence and recovered after ceasing ribavirin. Thus, ribavirin seems to be very effective for severe ad-hc for some recipients who receive transplants from a genetically close donor. Bone Marrow Transplantation (2000) 25, 545–548.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brugieres L, Hartmann O, Travagli JP et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome J Clin Oncol 1989 7: 194–199
Miyamura K, Takeyama K, Kojima S et al. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation BoneMarrow Transplant 1989 4: 533–535
Atkinson K, Biggs J, Noble G et al. Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis Bone Marrow Transplant 1987 2: 385–394
Seber A, Shu XO, Defor T et al. Risk factors for severe hemorrhagic cystitis following BMT Bone Marrow Transplant 1999 23: 35–40
Arthur RR, Shah KV, Baust SJ et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants New Engl J Med 1986 315: 230–234
Numazaki Y, Shigeta S, Kumasaka T et al. Acute hemorrhagic cystitis in children. Isolation of adenovirus type II New Engl J Med 1968 278: 700–704
Zahradnik JM, Spencer MJ, Porter DD . Adenovirus infection in the immunocompromised patient Am J Med 1980 68: 725–732
Fiala M, Payne JE, Berne TV et al. Role of adenovirus type 11 in hemorrhagic cystitis secondary to immunosuppression J Urol 1974 112: 595–597
Miyamura K, Minami S, Matsuyama T et al. Adenovirus-induced late onset hemorrhagic cystitis following allogeneic bone marrow transplantation (letter) Bone Marrow Transplant 1987 2: 109–110
Ambinder RF, Burns W, Forman M et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation Arch Intern Med 1986 146: 1400–1401
Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone marrow transplantation New Eng J Med 1985 312: 529–533
Flomenberg P, Babbitt J, Drobyski WR et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients J Infect Dis 1994 169: 775–781
Kohno A, Takeyama K, Narabayashi M et al. Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults Jap J Clin Oncol 1993 23: 46–52
Childs R, Sanchez C, Engler H et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystits in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine Bone Marrow Transplant 1998 22: 889–894
Trigg ME, O'Reilly J, Rumelhart S et al. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis J Urol 1990 143: 92–94
Cassano WF . Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation Bone Marrow Transplant 1991 7: 247–248
Murphy GF, Wood DP Jr, McRoberts JW et al. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin J Urol 1993 149: 565–566
Liles WC, Cushing H, Holt S et al. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin (see comments) Bone Marrow Transplant 1993 12: 409–412
Hromas R, Clark C, Blanke C et al. Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation (letter; comment) Bone Marrow Transplant 1994 14: 663–664
Jurado M, Navarro JM, Hernandez J et al. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin Bone Marrow Transplantation 1995 15: 651–652
Mann D, Moreb J, Smith S et al. Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report J Infect 1998 36: 227–228
Sao H, Kitaori K, Kasai M et al. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-versus-host disease in allogeneic bone marrow transplantation results of phase I–II trial Int J Hematol 1999 69: 27–35
Paroni R, Del Puppo M, Borghi C et al. Pharmacokinetics of ribavirin and urinary excretion of major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers Int J Clin Pharmacol 1989 27: 302–307
Hromas R, Cornetta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T cell-depleted bone marrow transplantation (letter) Blood 1994 84: 1689–1690
Flomenberg P, Piaskowski V, Truitt RL et al. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3–19K in the presence of gamma interferon J Virol 1996 70: 6314–6322
Acknowledgements
The authors are grateful to Miss Naoko Iwashima for the management of the import of ribavirin and Dr Gouji Kato, Makoto Hayashi and Yuko Kojima for patient information.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miyamura, K., Hamaguchi, M., Taji, H. et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 25, 545–548 (2000). https://doi.org/10.1038/sj.bmt.1702195
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702195
Keywords
This article is cited by
-
A Rare Case of Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplant Patient
Indian Journal of Hematology and Blood Transfusion (2016)
-
Late-onset hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation in patients with advanced leukemia: differences in ATG dosage are key
International Journal of Hematology (2013)
-
Selective embolization of the internal iliac arteries for the treatment of severe hemorrhagic cystitis following hematopoietic SCT
Bone Marrow Transplantation (2008)
-
Viral lower urinary tract infections
Current Prostate Reports (2007)